Life Science Analytics Market Is Expected to reach US$ 68.6 Billion by 2032

As per a report, the worldwide life science analytics market is assessed at US$ 22.1 Billion out of 2021 and is projected to arrive at US$ 24.8 Billion by 2022. It is anticipated that the market will develop at a CAGR of 10.7% somewhere in the range of 2022 and 2032. As per Future Market Experiences, the business is ready to arrive at a valuation of US$ 68.6 Billion toward the finish of the previously mentioned figure time frame.

With life science, artificial intelligence can be prepared to separate disease cells in the lab, examine complex genomic datasets, and recognize designs in clinical pictures, similar to x-beams. What’s more, analytics can likewise distinguish startling or novel examples and foresee treatment reactions by breaking down customer, treatment, demonstrative, and lab information put away in regular language.

Companies in the life sciences are finding it increasingly difficult to handle exponentially growing data volumes. Algorithms that use machine learning might be able to help analyze data and decide which parts of it are relevant, allowing huge amounts of data to be analyzed for insights.

Request a Sample Copy of this Report @

Moreover, AI can be used in repurposing drugs and developing new drugs, as well as in diagnosing diseases more swiftly and providing more efficient treatments, as well as identifying hypotheses based on data.

Key Takeaways

  • Life science analytics experienced a growth rate worth 11.8% between 2016 and 2021
  • The global life science analytics market is valued at US$ 39.9 Billion in 2026, during the forecast period.
  • Software components in the life science analytics segment to expand at a CAGR of 10.1% during the forecast period
  • In the U.S., the market is predicted to reach US$ 27.5 Billion while growing at a CAGR of 10.7% during the forecast period.
  • Life science analytics applications in research and development are expected to grow at a CAGR of 11.8% during the forecast period.
  • China’s market is expected to reach a market value of US$ 6.3 Billion with a CAGR of 18.6% during the forecast period.

“With custom solutions tailored to healthcare needs and a cloud that can deploy massive amounts of data, pharmaceutical companies will be able to garner much more value in the future,” says an FMI analyst.

Competitive Landscape

Key Players that have been profiled in the report are Accenture PLC, Cognizant Technology Solutions Corporation, IBM Corporation, MaxisIT, Inc., Oracle Corporation, IQVIA (Quintiles, Inc.), SAS Institute Inc., Scio Health Analytics, Take Solutions, Inc., Wipro Limited, and SAP SE are among companies that offer products and technologies that will allow customers to take advantage of new technologies.

  • In March 2022, EQT closes the acquisition of LSP and launches EQT Life Sciences. As announced on 10 November 2021, EQT AB completed the acquisition of LSP after signing a definitive agreement on 28 February 2022. EQT has issued 7,548,384 shares to LSP’s selling shareholders, representing a dilution of approximately 0.8 percent, as part of the total consideration of EUR 475 million. Following the completion of the Transaction, EQT will have 993,828,524 ordinary shares issued and outstanding.
  • For $2.2 billion, TPG Capital will purchase ClaimsXten, Change Healthcare’s claims editorial service, from UnitedHealth in April 2022. In order to proceed with ClaimsXten’s sale, UnitedHealth will have to acquire Change Healthcare first. The deal has been put on hold after the U.S. Department of Justice filed a lawsuit. Reports indicated that UnitedHealth hoped to acquire Change Healthcare for $8 billion through the sale of ClaimsXten.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global life science analytics market, presenting historical market data (2016-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on component (software and services), application (clinical and preclinical trials, regulatory compliance, research and development, sales and marketing and supply chain management), type (descriptive analysis, predictive analysis and prescriptive analysis), and end-use application (biomedical companies, laboratory, and pharmaceuticals and medical device companies across five major regions (North America, Europe, Asia Pacific, Middle East and Africa and South America).

Ask for Customization in the Report, Enquire Now @

Key Segments Covered in the Life Science Analytics Industry Report

Life Science Analytics by Component:

  • Life Science AnalyticsSoftware
    • On-premise Life Science Analytics Software
    • On-demand Life Science Analytics Software
  • Life Science AnalyticsServices
    • Professional Life Science Analytics Services
    • Managed Life Science Analytics Services

Life Science Analytics by Application:

  • Life Science Analyticsfor Clinical and Preclinical Trials
  • Life Science Analytics for Regulatory Compliance
  • Life Science Analytics for Research and Development
  • Life Science Analytics for Sales and Marketing
  • Life Science Analytics for Supply Chain Management

Life Science Analytics by Type:

  • Descriptive Life Science Analytics
  • Predictive Life Science Analytics
  • Prescriptive Life Science Analytics

Life Science Analytics by End-Use Application:

  • Life Science Analytics in Biomedical Companies
  • Life Science Analytics in Laboratory and Pharmaceuticals
  • Life Science Analytics in Medical Device Companies

Life Science Analytics by Region:

  • North America Life Science Analytics Market
  • Europe Life Science Analytics Market
  • Asia Pacific Life Science Analytics Market
  • Middle East and Africa Life Science Analytics Market
  • South America Life Science Analytics Market